Fulltext
Full-text is available in PDF format.
Acute Motor and Sensory Axonal Neuropathy, a Variant of Guillain-Barre Syndrome, Following COVID-19: A Case Report
Authors
1Department of Emergency Medicine, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
2Department of Midwifery, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
3Student Research Committee, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran
4Department of Neurology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: Department of Midwifery, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran. Email:honarmandpour.a@gmail.com
Published online:Oct 01, 2022
Article type:Case Report
Received:Jan 30, 2022
Accepted:Sep 19, 2022
How to Cite:Khalighi A, Honarmandpour A, Honarmandpour F, Mohamadi M. Acute Motor and Sensory Axonal Neuropathy, a Variant of Guillain-Barre Syndrome, Following COVID-19: A Case Report. Compr Health Biomed Stud. 2022;1(2):e142869. doi: https://doi.org/10.22034/hmrj.2022.327300.1044
Abstract
Introduction: Acute motor and sensory axonal neuropathy (AMSAN) is a variant of Guillain–Barré syndrome (GBS), characterized by acute paralysis and the loss of reflexes and sensory symptoms. The emerging evidence is growing to confirm that SARS‐CoV‐2 infection may be associated with neurological complications, including acute peripheral nerve diseases. Here we reported a case of AMSAN following the COVID-19 diagnosis.
Case presentation: A 59-year-old man with severe cold symptoms and the oral plague was diagnosed three weeks before the SARS-CoV-2 positive test results. Then the AMSAN disorder was confirmed after hospitalization and more laboratory, clinical, and electrophysiological investigations. However, interestingly, the patient revealed no respiratory symptom.
Conclusion: GBS can also occur in patients with COVID‐19 without respiratory symptoms. Since GBS syndrome can lead to patient mortality by involving the respiratory system, physicians should identify and treat early GBS and autonomic symptoms in coronavirus-affected individuals to prevent heart and respiratory failure. Accordingly, further studies on the early neurological symptoms of COVID‐19 and their consequences are recommended.
Highlights
Copyright
The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Similar Articles
19
May
2021
Guillain-Barre Syndrome in a Child Infected with COVID-19
Sedigheh Rafiei Tabatabaei,
Ghazal Shariatpanahi,
Romina Azadkiya,
Parvaneh Karimzadeh,
Abdollah Karimi
Rafiei Tabatabaei S, Shariatpanahi G, Azadkiya R, Karimzadeh P, Karimi A. Guillain-Barre Syndrome in a Child Infected with COVID-19. Arch Pediatr Infect Dis. 2022;10(Suppl):e113564. doi: https://doi.org/10.5812/pedinfect.113564
10
Mar
2021
Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report
Davood Shaliahmadi,
Kowsar Bavarsad,
Mohammad Momeni,
Roya Salehi Kahyesh,
Samireh Ghafouri
Shaliahmadi D, Bavarsad K, Momeni M, Salehi Kahyesh R, Ghafouri S. Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report. Jentashapir J Cell Mol Biol. 2021;12(1):e112645. doi: https://doi.org/10.5812/jjcmb.112645
31
Jul
2024
Investigation of Demographic, Clinical, Management and Outcome Characteristics Among Iranian Patients with GBS Following COVID Infection
Mehri Amiri,
Hadi Gharebaghian Azar
Amiri M, Gharebaghian Azar H. Investigation of Demographic, Clinical, Management and Outcome Characteristics Among Iranian Patients with GBS Following COVID Infection. Compr Health Biomed Stud. 2024;3(1):e145778. doi: https://doi.org/10.5812/chbs-145778
1
Oct
2020
Neurologic Manifestations of COVID-19: A Case Series of Iranian Patients
Farhad Malek,
Nooshin Masoodian,
Afshin Samaei,
Ali Gohari,
Sara Reshadat,
Hoda Aryan
,et al.Malek F, Masoodian N, Samaei A, Gohari A, Reshadat S, et al. Neurologic Manifestations of COVID-19: A Case Series of Iranian Patients. J Cell Mol Anesth. 2020;5(4):e149635. doi: https://doi.org/10.22037/jcma.v5i4.31261
30
Jun
2008
Acute Combined Demyelination of CNS and PNS: A Case Report
Parvaneh Karimzadeh,
N. Khosroshahi,
A.R. Khatami
Karimzadeh P, Khosroshahi N, Khatami A. Acute Combined Demyelination of CNS and PNS: A Case Report. I J Radiol. 2008;5(2):e78981. doi:
Cited by
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 0
Last Update: 0 months ago
- CrossRef: 0
Last Update: 6 minutes ago
- OpenAlex: 0
Last Update: 1 day ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0